Clarity Pharmaceuticals Ltd.ASX: CU6

Clarity Pharmaceuticals: Notice of Annual General Meeting/Proxy Form

· Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX · · 31 pages · English

Summary by 6ix AI

Clarity Pharmaceuticals Ltd. has issued a Notice of Annual General Meeting, inviting shareholders to attend the meeting scheduled for late November. The notice outlines the agenda, including the consideration of financial reports and various resolutions for shareholder approval. Key resolutions include the adoption of the Remuneration Report and the election and re-election of directors. Shareholders are encouraged to participate and vote, with details on proxy voting provided in the notice.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/notice-of-annual-general-meetingproxy-form-374

Release

A S X A N N O U N C E M E N T 23 October 2026 Annual General Meeting – Notice of Meeting Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), is pleased to present the Notice of Meeting for its upcoming Annual General Meeting to be held on 25 November 2026. For and on behalf of...

Clarity Pharmaceuticals Ltd. on 6ix

Earlier from Clarity Pharmaceuticals

Later from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases